Results 121 to 130 of about 9,290 (210)

One in One Million-A Case of Pleural Disease. [PDF]

Interdiscip Cardiovasc Thorac Surg
Byrne T, Blaskova S, Soo A.
europepmc   +1 more source

Precise control of selective nitrogen atom insertion into five-membered cyclic β-ketoesters. [PDF]

Nat Commun
Zhang Y, Wang J, Tao Y, Wang A, Shen G, Li Z, Zhang M, Yu B, Zhang X, Huang X.   +9 more
europepmc   +1 more source

Synthesis and reactivity of nitrogen-containing strained cyclic 1,2,3-trienes. [PDF]

Nat Synth
Witkowski DC, Turner DW, Bulger AS, Houk KN, Garg NK.   +4 more
europepmc   +1 more source

2-Pyridone-assisted palladium-catalyzed regioselective arylation of naphthamides. [PDF]

RSC Adv
Prajapati J, Chatterjee S.
europepmc   +1 more source

Optimization of 4-Amino-2-Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure-Activity and Structure-Metabolism Relationships. [PDF]

ChemMedChem
Giannessi L, Lupo MG, Ugolotti M, Papotti B, Mattina B, Martina MG, Demurtas A, Padula C, Nicoli S, Crescenzio M, Ferri N, Zimetti F, Radi M.   +12 more
europepmc   +1 more source

Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. [PDF]

Am J Case Rep
Babonji A, Algethmi FA, Almutairi BS, Alsulami A, Al-Mrzouki AF.   +4 more
europepmc   +1 more source

Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083. [PDF]

Clin Infect Dis
Brown TT, Arao RF, Warsi M, Phanuphak N, Vasconcelos R, Oyedele T, Sullivan PA, Hanscom B, Rooney JF, Rinehart AR, McCauley M, Grinsztejn B, Landovitz RJ.   +12 more
europepmc   +1 more source

Compound adsorption device in pathogen reduction technology removes multiple drugs from plasma components. [PDF]

Transfusion
Greenwall B, Reeder K, Anani WQ.
europepmc   +1 more source

Crystal structure, spectroscopy, DFT, and thermal studies of 3-cyano-2(1H)-pyridones as potential anticancer agents. [PDF]

RSC Adv
Hurtado-Rodríguez D, Becerra D, Rojas H, Gómez Castaño JA, Macías MA, Castillo JC.   +5 more
europepmc   +1 more source

Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention. [PDF]

Microbiol Spectr
Madzime RJ, van der Laan L, du Toit S, Barnabas S, Courtney I, Brown NE, Savic R, Solans BP, Dixon MG, Tsirizani L, Denti P, Boyd R, Hesseling AC, TBTC Study 35 team.   +13 more
europepmc   +1 more source